Cargando...
Pemetrexed and bevacizumab-containing chemotherapy for pleomorphic carcinoma of the lung
Pleomorphic carcinoma of the lung is a rare, highly malignant subtype of lung cancer, with a more aggressive clinical course compared with other types of non-small-cell lung cancer (NSCLC). Pemetrexed and bevacizumab are currently evaluated as two of the most reliable chemotherapeutic drugs for adva...
Guardado en:
| Publicado en: | Mol Clin Oncol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
D.A. Spandidos
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4812550/ https://ncbi.nlm.nih.gov/pubmed/27073676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.758 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|